John B Ancsin

Title: John B Ancsin: Innovator in Atherosclerosis Treatment

Introduction

John B Ancsin is a notable inventor based in Kingston, CA. He has made significant contributions to the field of medical research, particularly in the treatment of atherosclerosis. With a total of 3 patents, his work focuses on innovative compositions and methods aimed at improving cardiovascular health.

Latest Patents

Ancsin's latest patents include groundbreaking compositions and methods for treating atherosclerosis. These patents detail peptides and mimetics of selected domains of mammalian serum amyloid A isoform 2.1 (SAA2.1). The compounds and compositions provided enhance the effect on macrophage cholesterol ester hydrolase activity and inhibit acyl CoA:cholesterol acyl transferase activity. Furthermore, methods for using these compositions in the treatment and prevention of atherosclerosis, coronary heart disease, and cardiovascular disease are also outlined.

Career Highlights

Throughout his career, Ancsin has worked with prestigious institutions such as Queen's University at Kingston and the University of Chicago. His research has significantly advanced the understanding and treatment of cardiovascular diseases.

Collaborations

Ancsin has collaborated with esteemed colleagues, including Robert Kisilevsky and Shui-Pang Tam. These partnerships have fostered innovative research and development in his field.

Conclusion

John B Ancsin's contributions to the treatment of atherosclerosis through his innovative patents and collaborations highlight his importance in the medical research community. His work continues to pave the way for advancements in cardiovascular health.